Trial finds that enoxaparin may be the preferred drug for initiating anticoagulation in atrial fibrillation: Abstracted from: Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial. Circulation 2004; 109: 997-1003.

• Book ID: 116415755
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 126 KB
• Volume: 8
• Category: Article
• ISSN: 1361-2611
• DOI: 10.1016/j.ebcm.2004.06.038